News & Updates

Treatment with abrocitinib is both safe and effective in patients with moderate-to-severe atopic dermatitis (AD), regardless of prior dupilumab response status, a study has shown.

Poor lifestyle appears to increase the risk of incident psoriasis irrespective of genetic risk, suggest the results of a recent study. Additionally, lifestyle factors have a greater relative impact than genetic risk.

Treatment with the combination of ribociclib plus binimetinib appears to be well tolerated and delivers modest clinical activity in patients with locally advanced or metastatic melanoma harbouring NRAS mutation, according to the results of a phase Ib/II study.

A novel nitric oxide-releasing gel, berdazimer 10.3%, proves effective in the treatment of patients with water warts or molluscum contagiosum skin infection, facilitating clearance of lesions with low adverse event rates, as shown in the phase III B-SIMPLE4 trial.

Taking aspirin daily appears to do nothing in terms of reducing the risk of cutaneous melanoma in older individuals, according to a study.

Just as the world adapts to a new normal after the COVID-19 pandemic, a new outbreak of a not-so-new virus has been making headlines. But why the sudden concern?